Alendronate
- Product NDC
- 10135-696
- 11-digit product format
- 101350696
- Labeler code
- 10135
- Product ID
- 10135-696_76e6ead3-9532-4206-ad5f-a4a8a1eba934
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alendronate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA090258
- Marketing category
- ANDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- ALENDRONATE SODIUM
- Active strength
- 35 mg/1
- Pharmacologic classes
- Bisphosphonate [EPC],Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-696-12 | Alendronate | 3 in 1 CARTON | TABLET | 3 | | 1 |
| 10135-696-12 | Alendronate | 4 in 1 BLISTER PACK | TABLET | 4 | | 1 |
| 10135-696-44 | Alendronate | 1 in 1 CARTON | TABLET | 1 | | 1 |
| 10135-696-44 | Alendronate | 4 in 1 BLISTER PACK | TABLET | 4 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-696 | ALENDRONATE (ALENDRONATE SODIUM) TABLET [MARLEX PHARMACEUTICALS INC] | 1 | Legacy NDC, 4 package rows | 20200410_c1e61b54-287f-47ed-9192-e3c98ecb2e06.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-696-12 | 10135069612 | 3 BLISTER PACK in 1 CARTON (10135-696-12) > 4 TABLET in 1 BLISTER PACK | 3 blister pack | 2020-03-01 | 0000-00-00 | No | No | Current |
| 10135-696-44 | 10135069644 | 1 BLISTER PACK in 1 CARTON (10135-696-44) > 4 TABLET in 1 BLISTER PACK | 1 blister pack | 2020-03-01 | 0000-00-00 | No | No | Current |